Analysis of colorectal cancer morphology in relation to sex, age, location, and family history

Journal of Gastroenterology

Volumn 47, Issue 6, 2012, Pages 619-634

  Ghazi, Sam ^a   Lindforss, Ulrik ^a   Lindberg, Greger ^a   Berg, Elisabeth ^b   Lindblom, Annika ^a   Papadogiannakis, Nikos ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colorectal cancer; Familial; Histopathology; Location

Indexed keywords

MUCIN;

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER MORPHOLOGY; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; METASTASIS; MULTIPLE CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX; TUMOR ASSOCIATED LEUKOCYTE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MUCINS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SEX FACTORS;

EID: 84860546397     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0520-9     Document Type: Article

References (48)

1. George B, Kopetz S. Predictive and prognostic markers in colo-rectal cancer. Curr Oncol Rep. 2011 Epub ahead of print.
2. Woods SE, Narayanan K, Engel A. The influence of gender on colon cancer stage. J Womens Health. 2005;14:502-6. (Pubitemid 41479254)
3. Koo JH, Jalaludin B, Wong SK, Kneebone A, Connor SJ, Leong RW. Improved survival in young women with colorectal cancer. Am J Gastroenterol. 2008;6:1488-95. (Pubitemid 351813902)
4. Woods SE, Basho S, Engel AJ. The influence of gender on colorectal cancer stage: the state of Ohio, 1996-2001. J Womens Health. 2006;15:877-81. (Pubitemid 46381706)
5. Fairley TL, Cardinez CJ, Martin J, Alley L, Friedman C, Edwards B, et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer. 2006;107:1153-61. (Pubitemid 44384821)
6. Heys SD, Sherif A, Bagley JS, Brittenden J, Smart C, Eremin O. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg. 1994;81:685-8. (Pubitemid 24192094)
7. Snaebjornsson P, Jonasson L, Jonsson T, Möller PH, Theodors A, Jonasson JG. Colon cancer in Iceland\a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients' age. Int J Cancer. 2010;127:2645-53.
8. Nawa T, Kato J, Kawamoto H, Okada H, Yamamoto H, Kohno H, et al. Difference in right-and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23:418-23. (Pubitemid 351342058)
9. Meguid RA, Slidell MB, Wolfgang CL, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right-versus left-sided colon cancers? Ann Surg Oncol. 2008;15:2388-94.
10. Levi F, Randimbison L, La Vecchia C. Trends in subsite distribution of colorectal cancers and polyps from the Vaud Cancer Registry. Cancer. 1993;72:46-50. (Pubitemid 23182048)
11. Obrand DI, Gordon PH. Continued change in the distribution of colorectal carcinoma. Br J Surg. 1998;85:246-8. (Pubitemid 28099950)
12. Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology. 2003;124:1574-94. (Pubitemid 36617678)
13. Lindblom A, Ghazi S, Liu T, Lagerstedt K, Papadogiannakis N. Hereditary non-polyposis colorectal cancer (HNPCC); definition and diagnostics in 2005. Research Trends. 2006;2:21-31.
14. Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res. 1998;4:1-6. (Pubitemid 28062870)
15. Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, Wu R, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut. 2001;48:821-9. (Pubitemid 32476985)
16. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424-5.
17. Ghazi S, von Holst S, Picelli S, Lindforss U, Tenesa A, Farrington SM, et al. Colorectal cancer susceptibility loci in a population-based study: associations with morphological parameters. Am J Pathol. 2010;177:2688-93.
18. Wittekind C, Greene FL, Hutter RV, Sobin LH, Klimpfinger M. TNM atlas. 5th ed. Paris: Springer; 2005.
19. Hamilton SR, Aaltonen LA. World Health Organization classification of tumors, pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000.
20. Chandler I, Houlston RS. Interobserver agreement in grading colorectal cancers-findings from a nationwide web-based survey of histopathologists. Histopathology. 2008;52:494-9. (Pubitemid 351327987)
21. Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001;159: 2107-16. (Pubitemid 33104265)
22. Smyrk TC, Watson P, Kaul K, Lynch HT. Tumor infiltrating lymphocytes are a marker for microsatellite instability in colo-rectal carcinoma. Cancer. 2001;91:2417-22. (Pubitemid 32552830)
23. Jass Jr. Role of the pathologist in the diagnosis of hereditary non-polyposis colorectal cancer. Dis Marker. 2004;20: 215-24. (Pubitemid 40164094)
24. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumor "budding" as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127-32. (Pubitemid 34122114)
25. Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology. 1996;28:543-8.
26. Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, Leppert M, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001;9:917-23. (Pubitemid 32844897)
27. Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol. 2005;207:53-60. (Pubitemid 41200714)
28. Breivik J, Lothe RA, Meling GI, Meling GI, Rognum TO, Børresen-Dale AL, et al. Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer. 1997;74:664-9. (Pubitemid 28037512)
29. Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, et al. Estrogen reduces and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res. 2001;61:126-30. (Pubitemid 32095709)
30. Börger ME, Gosens MJEM, Jeuken JWM, van Kempen LC, van de Velde CJ, van Krieken JH, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212:278-86. (Pubitemid 47010061)
31. Gopalan V, Smith RA, Ho YH, Lam AK. Signet-ring cell carcinoma of colorectum-current perspectives and molecular biology. Int J Colorectal Dis. 2011;26:127-33.
32. Li F-Y, Lai M-D. Colorectal cancer, one entity or three. J Zhe-jiang Univ Sci B. 2009;10:219-29.
33. Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003;16:376-88. (Pubitemid 36443987)
34. Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum. 1991;34:798-804.
35. Lee YT. Local and regional recurrence of carcinoma of the colon and rectum: tumour-host factors and adjuvant therapy. Surg Oncol. 1995;4:283-93.
36. Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994;25:498-505.
37. Heys SD, O'Hanrahan TJ, Brittenden J, Eremin O. Colorectal cancers in young patients: A review of the literature. Eur J Surg Oncol. 1994;3:225-31. (Pubitemid 24166370)
38. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer. 1994;73:2076-82. (Pubitemid 24107961)
39. Michelassi F, Ayala JJ, Balestracci T, Goldberg R, Chappell R, Block GE. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Ann Surg. 1991;214:11-8.
40. Takebayashi Y, Akiyama SI, Yamada K, Akiba S, Aikou T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer. 1996;78:226-31. (Pubitemid 26234563)
41. Compton CC, Fielding L, Burgart LJ. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 1999;124:979-94.
42. Sternberg A, Amar A, Alfici R, Groisman G. Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J Clin Pathol. 2002;55:17-21. (Pubitemid 34081675)
43. Blenkinsopp WK, Stewart-Brown S, Blesovsky L, Kearney G, Fielding LP. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981;34:509-13. (Pubitemid 11063958)
44. Zlobec I, Höller S, Tornillo L, Terracciano L, Lugli A. Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer. Dis Colon Rectum. 2009;52:1114-21.
45. Lin M, Lin H-Z, Ma S-P, Ji P, Xie D, Yu JX. Vascular endothelial growth factor-A and-C: expression and correlations with lymphatic metastases and prognosis in colorectal cancer. Med Oncol. 2011;28:151-8.
46. Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst. 2007;99:291-9. (Pubitemid 47073492)
47. Olsson L, Lindblom A. Family history of colorectal cancer in a Swedish county. Fam Cancer. 2003;2:87-93. (Pubitemid 37247980)
48. Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histo-logical categorization of fibrotic cancer stroma in advanced rectal cancer. Gut. 2004;53:581-6. (Pubitemid 38372985)